Anyway I don't think dilution will be avoidable. I think it is looming ... However it shall be the last hurting news to the pps, afterwards only a stream of good news !
PS : Regarding the needs in cash "$17.2 million." I don't know what it means but certainly will not be enough to complete phase III. Beware Cel Sci figures : count on at least the double figure (30 to 40 M) to complete the clinical trials. Settlement plus 1 or 2 dilutions (helped by solid figures/new) shall help.
According to my calculations on cash-on-hand a few months ago (please look according post), a dilution should happen whatever the outcome in the Inventiv case. May be around April
(haven't looked at latests statements from CVM though, might be worth )
in any case, those SB of inventive hoping to win ... I think once again they are trying to gain time